Submitted by Anonymous (not verified) on 8 July 2025 - 9:47
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 14, Status: Authorised